CRL vs INSM · rev $2.00B vs rev $731.5M
Charles River Laboratories (CRL) versus Insmed Inc (INSM) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Insmed Inc (INSM) is a biotechnology company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported INSM revenue for 2026-06-30 was $731.5M. Net income was -$176.8M. INSM currently screens at market cap $20.42B.
CRL currently screens at market cap $7.78B. INSM currently screens at market cap $20.42B.
Not investment advice. Open the CRL and INSM stock pages for the full models.
Not investment advice.